Related Experiment Video
Updated: Mar 1, 2026

06:28
E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
9.3K
TELEHEALTH ALLOWS FOR CLINICAL TRIAL PARTICIPATION AND MULTIMODALITY THERAPY IN A RURAL PATIENT WITH STAGE 4
James M Clark1, Laurence J Heifetz2, Daphne Palmer3
1Section of General Thoracic Surgery, Department of Surgery, UC Davis Medical Center, 2315 Stockton Blvd, Sacramento, CA 95817, USA.
Cancer Treatment and Research Communications
|June 6, 2017
Summary
Rural patients with advanced non-small cell lung cancer (NSCLC) can achieve remission with multi-modal therapy. Telehealth facilitated this rural patient
Area of Science:
- Oncology
- Rural Health
- Telemedicine
Background:
- Oligometastatic non-small cell lung cancer (NSCLC) presents poor prognosis in rural settings.
- Rural populations face healthcare disparities for complex malignancies.
- Telehealth integration can improve outcomes for rural cancer patients.
Purpose of the Study:
- To present a case of successful multi-modal therapy for a rural patient with stage IV NSCLC.
- To highlight the role of telehealth in facilitating complex cancer care for rural populations.
Main Methods:
- A case study of a rural patient with stage IV NSCLC.
- Implementation of trimodality therapy including surgical resection.
- Facilitation of care and clinical trial participation via telehealth.
Main Results:
- The patient achieved clinical complete remission and remained disease-free for 18 months.
- Telehealth enabled participation in clinical trials and tertiary care consultations.
- Successful integration of advanced cancer treatment in a rural setting.
Conclusions:
- Multi-modality therapy, including surgery, can significantly improve survival in oligometastatic NSCLC.
- Telehealth is a valuable tool for overcoming geographical barriers in complex cancer care.
- This case demonstrates the feasibility and benefit of advanced cancer treatment facilitated by telehealth for rural patients.
Related Concept Videos
Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Clinical Trials
11.0K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
11.0K
Clinical Trials: Overview
5.2K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.2K
